WallStreetZenWallStreetZen

NASDAQ: APLT
Applied Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for APLT

Based on 4 analysts offering 12 month price targets for Applied Therapeutics Inc.
Min Forecast
$7.00+67.06%
Avg Forecast
$11.00+162.53%
Max Forecast
$13.00+210.26%

Should I buy or sell APLT stock?

Based on 4 analysts offering ratings for Applied Therapeutics Inc.
Strong Buy
Strong Buy
2 analysts 50%
Buy
2 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their APLT stock forecasts and price targets.

APLT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-11
lockedlocked$00.00+00.00%2024-03-15Find Out Why
lockedlocked$00.00+00.00%2024-02-22
lockedlocked$00.00+00.00%2024-02-16Find Out Why

1 of 1

Forecast return on equity

Is APLT forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
34.27%

Forecast return on assets

Is APLT forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

APLT revenue forecast

What is APLT's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$10.2M
Avg 2 year Forecast
$59.2M
Avg 3 year Forecast
$82.6M

APLT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
APLT$4.19$11.00+162.53%Strong Buy
URGN$13.22$43.00+225.26%Buy
CRBP$45.00$61.00+35.56%Strong Buy
HRTX$3.20$5.50+71.88%Buy
TCRX$8.98$11.40+26.95%Strong Buy
View Top Biotech Stocks

Applied Therapeutics Stock Forecast FAQ

Is Applied Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NASDAQ: APLT) stock is to Strong Buy APLT stock.

Out of 4 analysts, 2 (50%) are recommending APLT as a Strong Buy, 2 (50%) are recommending APLT as a Buy, 0 (0%) are recommending APLT as a Hold, 0 (0%) are recommending APLT as a Sell, and 0 (0%) are recommending APLT as a Strong Sell.

If you're new to stock investing, here's how to buy Applied Therapeutics stock.

What is APLT's revenue growth forecast for 2024-2026?

(NASDAQ: APLT) Applied Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.95%.

Applied Therapeutics's revenue in 2024 is -$477,000.On average, 1 Wall Street analysts forecast APLT's revenue for 2024 to be $1,165,527,296, with the lowest APLT revenue forecast at $1,165,527,296, and the highest APLT revenue forecast at $1,165,527,296. On average, 1 Wall Street analysts forecast APLT's revenue for 2025 to be $6,764,629,014, with the lowest APLT revenue forecast at $6,764,629,014, and the highest APLT revenue forecast at $6,764,629,014.

In 2026, APLT is forecast to generate $9,438,485,753 in revenue, with the lowest revenue forecast at $9,438,485,753 and the highest revenue forecast at $9,438,485,753.

What is APLT's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: APLT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is APLT's Price Target?

According to 4 Wall Street analysts that have issued a 1 year APLT price target, the average APLT price target is $11.00, with the highest APLT stock price forecast at $13.00 and the lowest APLT stock price forecast at $7.00.

On average, Wall Street analysts predict that Applied Therapeutics's share price could reach $11.00 by Apr 11, 2025. The average Applied Therapeutics stock price prediction forecasts a potential upside of 162.53% from the current APLT share price of $4.19.

What is APLT's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: APLT) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.